What is FCZBL's earnings per share (EPS)?

FCZBL (FCZBL) reported diluted earnings per share of $165.24 for fiscal year 2025. This represents a -12.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

FCZBL Financials

FCZBL

Trailing 12 months to March 31, 2026

Revenue $9.6B -0.6% YoY

Net Income $2.3B -10.8% YoY

EPS (Diluted) $165.24 FY2025 annual

Free Cash Flow $2.2B +2.8% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 8, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 8, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FCZBL SEC filings page.

FCZBL (FCZBL) reported $9.6B in revenue over the twelve months to Mar 31, 2026, down 0.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FCZBL FY2025 2026-08-30

FCZBL’s dominant mechanic is asset-heavy, liability-funded earnings, with cash conversion holding while interest expense compresses reported profitability.

The sharpest shift is the weakening of reported profitability: net margin fell from 61.0% in FY2023 to 23.1% in FY2025, while interest expense reached $4.96B. Combined with debt-to-equity of 1.6x, this indicates that financing costs—not merely operating scale—now materially shape earnings available to equity holders.

In FY2025, operating cash flow of $2.92B nearly matched net income of $2.21B, indicating that reported earnings were broadly cash-backed rather than primarily accounting accruals. Free cash flow remained positive after capital expenditures of $710M, showing reinvestment consumes part, but not all, of internally generated cash.

The balance sheet is structurally leveraged: total liabilities of $207.5B were nearly ten times $22.2B of equity in FY2025. Despite that posture, debt-to-equity eased from 175.0% in FY2023 to 160.9% in FY2025, while buybacks exceeded dividends, directing more cash toward repurchases than shareholder distributions.

Financial Health Signals

Financial health score not available

FCZBL does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

4/6

FCZBL passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.33x

For every $1 of reported earnings, FCZBL generates $1.33 in operating cash flow ($2.9B OCF vs $2.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.3B

YoY+0.7%

QoQ-5.1%

5Y CAGR+45.5%

10Y CAGR+25.3%

FCZBL generated $2.3B in revenue in Q1 2026. This represents an increase of 0.7% from the same quarter a year earlier. Against the prior quarter it is down 5.1%.

Net Income

$534.0M

YoY+10.6%

QoQ-7.9%

5Y CAGR+29.4%

10Y CAGR+26.2%

FCZBL reported $534.0M in net income in Q1 2026. This represents an increase of 10.6% from the same quarter a year earlier. Against the prior quarter it is down 7.9%.

EPS (Diluted)

$42.63

YoY+23.7%

FCZBL earned $42.63 per diluted share (EPS) in Q1 2026. This represents an increase of 23.7% from the same quarter a year earlier.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Free Cash Flow

$31.0M

YoY+720.0%

QoQ-96.2%

5Y CAGR-21.0%

10Y CAGR-6.6%

FCZBL generated $31.0M in free cash flow in Q1 2026, representing cash available after capex. This represents an increase of 720.0% from the same quarter a year earlier. Against the prior quarter it is down 96.2%.

Cash & Debt

$1.1B

YoY+33.0%

QoQ+34.8%

5Y CAGR+21.4%

10Y CAGR+9.0%

FCZBL held $1.1B in cash against $33.8B in long-term debt as of Q1 2026.

Dividends Per Share

$2.10

YoY+7.7%

FCZBL paid $2.10 per share in dividends in Q1 2026. This represents an increase of 7.7% from the same quarter a year earlier.

Shares Outstanding

Diluted avg 12M

FCZBL had a weighted average of 12M diluted shares in Q1 2026; the shares outstanding count is not reported for that period.

Margins & Returns

Net Margin

23.1%

YoY+2.1pp

QoQ-0.7pp

5Y change-18.3pp

10Y change+1.7pp

FCZBL's net profit margin was 23.1% in Q1 2026, showing the share of revenue converted to profit. This is up 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Return on Equity

2.4%

YoY+0.2pp

QoQ-0.2pp

5Y change-1.0pp

10Y change+0.7pp

FCZBL's ROE was 2.4% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Capital Allocation

Share Buybacks

$899.0M

YoY+45.5%

QoQ-0.1%

FCZBL spent $899.0M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 45.5% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.

Capital Expenditures

$141.0M

YoY+36.9%

QoQ-42.0%

5Y CAGR+41.3%

10Y CAGR+26.4%

FCZBL invested $141.0M in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 36.9% from the same quarter a year earlier. Against the prior quarter it is down 42.0%.

R&D Spending

Not reported for Q1 2026.

FCZBL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FCZBL quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$9.6B	$9.5B-2.2%	$9.8B-48.1%	$18.8B+269.7%	$5.1B+250.2%	$1.5B-2.2%	$1.5B+5.7%	$1.4B+12.7%	$1.2B+12.9%	$1.1B+11.7%	$987.8M+1.9%	$969.2M+27.5%	$760.4M-4.6%	$796.8M-20.7%	$1.0B-1.0%	$1.0B
SG&A Expenses	$3.3B	$3.3B+7.0%	$3.1B+16.8%	$2.6B+87.2%	$1.4B+85.5%	$759.0M+5.1%	$722.0M-34.6%	$1.1B+2.5%	$1.1B+6.4%	$1.0B+8.0%	$937.8M-9.7%	$1.0B+22.4%	$849.1M+10.1%	$771.4M+0.6%	$766.9M-3.3%	$792.9M
Interest Expense	$4.9B	$5.0B-4.7%	$5.2B+41.6%	$3.7B+687.8%	$467.0M+665.6%	$61.0M-36.5%	$96.0M+3.6%	$92.6M+151.4%	$36.9M-15.8%	$43.8M+1.7%	$43.1M-2.8%	$44.3M-12.0%	$50.4M-11.1%	$56.6M-37.2%	$90.1M-37.5%	$144.2M
Income Tax	$768.0M	$765.0M-6.1%	$815.0M+33.4%	$611.0M+131.4%	$264.0M+71.4%	$154.0M+22.2%	$126.0M-6.4%	$134.7M+30.4%	$103.3M-53.0%	$219.9M+75.1%	$125.6M+2.9%	$122.0M+87.6%	$65.0M-36.0%	$101.6M+56.9%	$64.7M-43.8%	$115.1M
Net Income	$2.3B	$2.2B-20.6%	$2.8B-75.8%	$11.5B+944.3%	$1.1B+100.7%	$547.0M+11.2%	$492.0M+7.6%	$457.4M+14.3%	$400.3M+23.6%	$323.8M+43.6%	$225.5M+7.2%	$210.4M+51.8%	$138.6M-17.0%	$166.9M+26.0%	$132.4M-32.1%	$195.0M
EPS (Basic)	N/A	$165.24-12.8%	$189.42-75.9%	$785.14+1063.7%	$67.47+25.2%	$53.88+13.4%	$47.50+15.7%	$41.05+22.4%	$33.53+11.9%	$29.96+59.6%	$18.77+7.1%	$17.52+29.2%	$13.56-21.8%	$17.35+34.3%	$12.92-31.3%	$18.80
EPS (Diluted)	—	$165.24-12.8%	$189.41-75.9%	$784.51+1064.0%	$67.40	$53.88+13.4%	$47.50	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	13M-9.3%	14M-1.4%	15M-6.5%	16M	10M-2.4%	10M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$2.3B+0.7%	$2.4B+1.2%	$2.4B-0.5%	$2.4B-3.5%	$2.3B-6.0%	$2.4B-79.1%	$2.4B-21.4%	$2.5B-16.7%
SG&A Expenses	$869.0M+6.2%	$849.0M+6.0%	$817.0M+3.7%	$810.0M+8.7%	$818.0M+9.9%	$801.0M+12.2%	$788.0M+8.4%	$745.0M-3.9%
Interest Expense	$1.2B-5.4%	$1.2B-5.7%	$1.3B-5.8%	$1.3B-4.5%	$1.2B-2.8%	$1.3B+7.1%	$1.3B+19.8%	$1.3B+32.0%
Income Tax	$171.0M+1.8%	$231.0M+541.7%	$183.0M-21.8%	$183.0M-32.7%	$168.0M-38.5%	$36.0M-81.9%	$234.0M-4.5%	$272.0M+27.1%
Net Income	$534.0M+10.6%	$580.0M-17.1%	$568.0M-11.1%	$575.0M-18.7%	$483.0M-33.9%	$700.0M+36.2%	$639.0M-15.0%	$707.0M+3.7%
EPS (Basic)	$42.63+23.7%	N/A	$43.08-0.8%	$42.36-10.9%	$34.47-30.0%	N/A	$43.42-14.4%	$47.54+3.6%
EPS (Diluted)	$42.63+23.7%	N/A	$43.08-0.8%	$42.36-10.9%	$34.47-30.0%	N/A	$43.42-14.3%	$47.54+3.6%
Diluted Shares (Avg)	12M-12.2%	N/A	13M-10.6%	13M-8.9%	14M-6.6%	N/A	14M-1.1%	15M0.0%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

FCZBL Balance Sheet

FCZBL quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$229.7B+2.7%	$223.7B+4.7%	$213.8B+95.6%	$109.3B+87.4%	$58.3B+16.7%	$50.0B+25.4%	$39.8B+12.5%	$35.4B+2.6%	$34.5B+4.7%	$33.0B+4.8%	$31.5B+4.7%	$30.1B+41.9%	$21.2B-0.4%	$21.3B+1.4%	$21.0B
Cash & Equivalents	$801.0M-1.6%	$814.0M-10.4%	$908.0M+75.3%	$518.0M-94.3%	$9.0B+111.5%	$4.3B+1033.5%	$376.7M+15.0%	$327.4M-2.6%	$336.1M-37.7%	$539.7M+1.1%	$534.1M-11.6%	$604.2M+13.2%	$533.6M-16.6%	$639.7M+8.3%	$590.8M
Accounts Receivable	N/A	N/A	N/A	N/A	$862.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$346.0M0.0%	$346.0M0.0%	$346.0M0.0%	$346.0M0.0%	$346.0M-1.1%	$350.0M+0.2%	$349.4M+47.8%	$236.3M+56.9%	$150.6M0.0%	$150.6M+7.7%	$139.8M0.0%	$139.8M+36.2%	$102.6M0.0%	$102.6M0.0%	$102.6M
Total Liabilities	$207.5B+3.0%	$201.5B+4.7%	$192.5B+93.2%	$99.6B+86.0%	$53.6B+17.2%	$45.7B+26.2%	$36.2B+13.5%	$31.9B+2.3%	$31.2B+4.1%	$30.0B+4.8%	$28.6B+4.4%	$27.4B+43.2%	$19.1B-1.5%	$19.4B+1.5%	$19.1B
Long-Term Debt	$35.8B-2.5%	$36.7B-1.3%	$37.2B+733.6%	$4.5B+273.1%	$1.2B-4.3%	$1.2B+112.0%	$588.6M+4128.4%	$13.9M-98.4%	$870.2M+4.5%	$832.9M+18.3%	$704.2M+100.4%	$351.3M-31.2%	$510.8M+14.8%	$444.9M-35.3%	$687.6M
Total Equity	$22.2B0.0%	$22.2B+4.6%	$21.3B+120.0%	$9.7B+103.9%	$4.7B+12.0%	$4.2B+17.9%	$3.6B+2.8%	$3.5B+4.6%	$3.3B+10.7%	$3.0B+4.9%	$2.9B+6.9%	$2.7B+29.7%	$2.1B+11.4%	$1.9B-0.1%	$1.9B
Retained Earnings	$20.8B+7.3%	$19.4B+15.6%	$16.7B+210.5%	$5.4B+23.2%	$4.4B+13.2%	$3.9B+5.7%	$3.7B+13.7%	$3.2B+15.5%	$2.8B+12.5%	$2.5B+9.3%	$2.3B+9.5%	$2.1B+6.5%	$1.9B+8.4%	$1.8B+1.1%	$1.8B

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$236.0B+3.1%	$229.7B+2.7%	$233.5B+5.9%	$229.7B+4.5%	$228.8B+5.0%	$223.7B+4.7%	$220.6B+3.2%	$219.8B+4.9%
Cash & Equivalents	$1.1B+33.0%	$801.0M-1.6%	$874.0M+1.4%	$889.0M+16.4%	$812.0M+16.3%	$814.0M-10.4%	$862.0M+9.0%	$764.0M-16.7%
Goodwill	$346.0M0.0%	$346.0M0.0%	$346.0M0.0%	$346.0M0.0%	$346.0M0.0%	$346.0M0.0%	$346.0M0.0%	$346.0M0.0%
Total Liabilities	$213.9B+3.6%	$207.5B+3.0%	$211.5B+7.0%	$207.4B+5.1%	$206.5B+5.4%	$201.5B+4.7%	$197.7B+2.3%	$197.3B+4.0%
Long-Term Debt	$33.8B-11.0%	$35.8B-2.5%	$38.3B+4.0%	$37.6B+1.5%	$38.0B+2.2%	$36.7B-1.3%	$36.8B-1.3%	$37.1B-6.6%
Total Equity	$22.0B-1.1%	$22.2B0.0%	$22.0B-3.7%	$22.3B-0.8%	$22.3B+2.0%	$22.2B+4.6%	$22.8B+12.0%	$22.5B+13.7%
Retained Earnings	$20.3B+2.7%	$20.8B+7.3%	$20.9B+11.6%	$20.3B+12.3%	$19.8B+13.6%	$19.4B+15.6%	$18.7B+15.0%	$18.1B+16.5%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities.

FCZBL Cash Flow Statement

FCZBL quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$3.0B	$2.9B-2.2%	$3.0B+12.3%	$2.7B-4.7%	$2.8B+1082.7%	-$284.0M-175.5%	$376.0M-35.0%	$578.2M+27.4%	$453.8M+27.7%	$355.3M+54.1%	$230.5M-1.1%	$233.1M+27.9%	$182.2M-44.9%	$331.0M+64.4%	$201.3M-40.0%	$335.7M
Depreciation & Amortization	N/A	$314.0M+13.8%	$276.0M+22.7%	$225.0M+58.5%	$142.0M+32.7%	$107.0M-1.8%	$109.0M+5.0%	$103.8M+7.3%	$96.8M+6.6%	$90.8M+2.3%	$88.8M+1.2%	$87.7M+16.2%	$75.5M+6.5%	$70.8M+2.8%	$68.9M+5.8%	$65.2M
Stock-Based Compensation	N/A	$0	$0-100.0%	$5.0M-73.7%	$19.0M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	$748.0M	$710.0M+65.5%	$429.0M+5.9%	$405.0M+161.3%	$155.0M+44.9%	$107.0M-19.5%	$133.0M+9.8%	$121.1M-13.8%	$140.4M+65.6%	$84.8M+3.6%	$81.8M-8.8%	$89.7M+8.5%	$82.7M+25.2%	$66.0M-25.7%	$88.9M+15.6%	$76.9M
Free Cash Flow	$2.2B	$2.2B-13.5%	$2.6B+13.5%	$2.3B-14.5%	$2.6B+774.2%	-$391.0M-260.9%	$243.0M-46.8%	$457.2M+45.9%	$313.3M+15.8%	$270.5M+81.9%	$148.7M+3.7%	$143.3M+44.0%	$99.5M-62.4%	$265.0M+135.7%	$112.4M-56.6%	$258.8M
Investing Cash Flow	-$7.3B	-$5.6B+44.7%	-$10.2B-518.1%	$2.4B+3138.7%	$75.0M+101.0%	-$7.6B+23.6%	-$9.9B-520.7%	-$1.6B-1678.2%	$101.1M+115.1%	-$668.7M	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$4.5B	$2.7B-62.2%	$7.1B+250.5%	-$4.7B-74.9%	-$2.7B-134.3%	$7.8B-17.7%	$9.5B+791.8%	$1.1B+289.3%	-$563.6M-613.2%	$109.8M	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	$170.0M	$161.0M+1.9%	$158.0M+35.0%	$117.0M+41.0%	$83.0M+97.6%	$42.0M+40.0%	$30.0M+65.4%	$18.1M+8.1%	$16.8M+16.4%	$14.4M0.0%	$14.4M-20.0%	$18.0M+56.1%	$11.5M+33.2%	$8.7M-43.7%	$15.4M+23.2%	$12.5M
Share Buybacks	$3.3B	$3.0B+83.7%	$1.6B	$0-100.0%	$1.2B	$0-100.0%	$334.0M-26.3%	$453.1M+177.8%	$163.1M	$0	$0	$0	$0-100.0%	$321K-99.7%	$103.6M+324.9%	$24.4M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	$172.0M+75.5%	$1.1B-6.2%	$916.0M-7.6%	$859.0M+106.0%	$98.0M-78.7%	$1.1B+24.2%	$991.0M-17.8%	$417.0M-54.5%
Depreciation & Amortization	$180.0M+93.5%	N/A	N/A	N/A	$93.0M+875.0%	N/A	N/A	N/A
Capital Expenditures	$141.0M+36.9%	$243.0M+89.8%	$238.0M+124.5%	$126.0M+24.8%	$103.0M+9.6%	$128.0M-38.5%	$106.0M+53.6%	$101.0M+20.2%
Free Cash Flow	$31.0M+720.0%	$807.0M-18.6%	$678.0M-23.4%	$733.0M+132.0%	-$5.0M-101.4%	$991.0M+43.0%	$885.0M-22.1%	$316.0M-62.0%
Investing Cash Flow	-$6.5B-34.0%	$3.6B+196.9%	-$3.8B-1162.8%	-$562.0M+69.1%	-$4.9B-13.7%	-$3.7B-945.8%	-$301.0M+92.0%	-$1.8B-146.5%
Financing Cash Flow	$6.6B+39.1%	-$4.8B-284.4%	$2.9B+584.8%	-$220.0M-115.0%	$4.8B+32.0%	$2.6B+704.9%	-$592.0M-124.4%	$1.5B+126.6%
Dividends Paid	$51.0M+21.4%	$40.0M-4.8%	$39.0M+2.6%	$40.0M+2.6%	$42.0M+7.7%	$42.0M+7.7%	$38.0M+46.2%	$39.0M+50.0%
Share Buybacks	$899.0M+45.5%	$900.0M-5.1%	$896.0M+28.0%	$613.0M	$618.0M	$948.0M	$700.0M	$0

Not reported in any period shown, so not listed: Stock-Based Compensation.

FCZBL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FCZBL quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Net Margin	23.1%-5.3pp	28.5%-32.6pp	61.0%+39.4pp	21.6%-16.1pp	37.7%+4.5pp	33.1%+0.6pp	32.6%+0.5pp	32.1%+2.8pp	29.3%+6.5pp	22.8%+1.1pp	21.7%+3.5pp	18.2%-2.7pp	20.9%+7.8pp	13.2%-6.0pp	19.2%
Return on Equity	9.9%-2.6pp	12.5%-41.4pp	53.9%+42.6pp	11.4%-0.2pp	11.5%-0.1pp	11.6%-1.1pp	12.8%+1.3pp	11.5%+1.8pp	9.7%+2.2pp	7.5%+0.2pp	7.3%+2.2pp	5.2%-2.9pp	8.1%+0.9pp	7.1%-3.4pp	10.5%
Return on Assets	1.0%-0.3pp	1.2%-4.1pp	5.4%+4.4pp	1.0%+0.1pp	0.9%0.0pp	1.0%-0.2pp	1.1%0.0pp	1.1%+0.2pp	0.9%+0.3pp	0.7%0.0pp	0.7%+0.2pp	0.5%-0.3pp	0.8%+0.2pp	0.6%-0.3pp	0.9%
Debt-to-Equity	1.610.0x	1.65-0.1x	1.75+1.3x	0.46+0.2x	0.250.0x	0.30+0.1x	0.16+0.1x	0.09-0.2x	0.260.0x	0.280.0x	0.25+0.1x	0.13-0.1x	0.250.0x	0.24-0.1x	0.37
Asset Turnover	0.040.0x	0.040.0x	0.090.0x	0.050.0x	0.020.0x	0.030.0x	0.040.0x	0.040.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.040.0x	0.050.0x	0.05
FCF Margin	23.2%-3.0pp	26.2%+14.2pp	12.0%-39.9pp	51.9%+78.8pp	-27.0%-43.3pp	16.4%-16.2pp	32.6%+7.4pp	25.1%+0.6pp	24.5%+9.5pp	15.0%+0.3pp	14.8%+1.7pp	13.1%-20.2pp	33.3%+22.1pp	11.2%-14.3pp	25.5%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Net Margin	23.1%+2.1pp	23.8%-5.3pp	23.4%-2.8pp	24.2%-4.5pp	21.0%-8.9pp	29.1%+24.6pp	26.1%+1.9pp	28.7%+5.6pp
Return on Equity	2.4%+0.2pp	2.6%-0.5pp	2.6%-0.2pp	2.6%-0.6pp	2.2%-1.2pp	3.1%+0.7pp	2.8%-0.9pp	3.1%-0.3pp
Return on Assets	0.2%0.0pp	0.3%-0.1pp	0.2%-0.1pp	0.3%-0.1pp	0.2%-0.1pp	0.3%+0.1pp	0.3%-0.1pp	0.3%0.0pp
Debt-to-Equity	1.53-0.2x	1.610.0x	1.74+0.1x	1.690.0x	1.700.0x	1.65-0.1x	1.61-0.2x	1.65-0.4x
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x
FCF Margin	1.3%+1.6pp	33.1%-8.0pp	27.9%-8.3pp	30.9%+18.0pp	-0.2%-15.2pp	41.1%+35.1pp	36.2%-0.4pp	12.8%-15.3pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Where FCZBL Ranks

Frequently Asked Questions

What is FCZBL's annual revenue?

FCZBL (FCZBL) reported $9.5B in total revenue for fiscal year 2025. This represents a -2.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is FCZBL's revenue growing?

FCZBL (FCZBL) revenue declined by 2.2% year-over-year, from $9.8B to $9.5B in fiscal year 2025.

Is FCZBL profitable?

Yes, FCZBL (FCZBL) reported a net income of $2.2B in fiscal year 2025, with a net profit margin of 23.1%.

How much debt does FCZBL have?

As of fiscal year 2025, FCZBL (FCZBL) had $801.0M in cash and equivalents against $35.8B in long-term debt.

What is FCZBL's net profit margin?

FCZBL (FCZBL) had a net profit margin of 23.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does FCZBL pay dividends?

Yes, FCZBL (FCZBL) paid $7.95 per share in dividends during fiscal year 2025.

What is FCZBL's return on equity (ROE)?

FCZBL (FCZBL) has a return on equity of 9.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is FCZBL's free cash flow?

FCZBL (FCZBL) generated $2.2B in free cash flow during fiscal year 2025. This represents a -13.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is FCZBL's operating cash flow?

FCZBL (FCZBL) generated $2.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are FCZBL's total assets?

FCZBL (FCZBL) had $229.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are FCZBL's capital expenditures?

FCZBL (FCZBL) invested $710.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does FCZBL buy back shares?

Yes, FCZBL (FCZBL) spent $3.0B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is FCZBL's debt-to-equity ratio?

FCZBL (FCZBL) had a debt-to-equity ratio of 1.61 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is FCZBL's return on assets (ROA)?

FCZBL (FCZBL) had a return on assets of 1.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is FCZBL's Piotroski F-Score?

FCZBL (FCZBL) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are FCZBL's earnings high quality?

FCZBL (FCZBL) has an earnings quality ratio of 1.33x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.